| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -715,274 | -605,150 |
| Depreciation and amortization | 1,633,457 | 1,002,978 |
| Non-cash lease expense | 233,836 | 144,113 |
| Amortization of debt discounts and issuance costs and accretion of redemption premiums | 87,776 | 66,727 |
| Loss (gain) on fair value adjustments | 26,837 | 26,837 |
| Stock-based compensation | 473,409 | 328,978 |
| Debt extinguishment loss | -14,486 | - |
| Deferred income taxes | -37,141 | 90,884 |
| Other non-cash reconciling items | 49,388 | 40,132 |
| Accounts receivable | 1,252,507 | 1,504,696 |
| Prepaid expenses and other current assets | 171,034 | 120,448 |
| Accounts payable and accrued expenses | 333,211 | -289,173 |
| Deferred revenue | 1,402,164 | 742,892 |
| Lease liabilities | -181,061 | -110,451 |
| Other non-current assets | 344,822 | -49,968 |
| Other liabilities | 0 | - |
| Net cash provided by operating activities | 1,499,051 | -190,083 |
| Purchase of property and equipment, including capitalized internal-use software | 6,249,239 | 3,860,351 |
| Sale of available-for-sale marketable securities | 0 | 0 |
| Maturities of marketable securities | 29,308 | 29,308 |
| Purchase of marketable securities | 47,246 | 0 |
| Purchase of strategic investments | 0 | 0 |
| Sale of warrants received as lease incentive | 100,645 | 100,645 |
| Business combinations, net of cash acquired | 55,918 | 45,706 |
| Issuance of notes receivable | 73,000 | 73,000 |
| Other investing activities | 49,849 | 26,109 |
| Net cash used in investing activities | -6,345,299 | -3,875,213 |
| Proceeds from issuance of debt | 7,562,686 | 4,432,723 |
| Repayments of debt | 2,978,850 | 1,574,867 |
| Payment of debt issuance costs | 46,086 | 36,536 |
| Issuance of redeemable convertible preferred stock, net of issuance costs | 0 | 0 |
| Redeemable convertible preferred stock cash dividends paid | 28,693 | 28,693 |
| Proceeds from exercise of stock options | 17,519 | 4,538 |
| Proceeds from initial public offering, net of underwriting discounts and commissions | 1,422,619 | 1,422,619 |
| Issuance of common stock in connection with over-allotment exercise, net of underwriting discounts and commissions | 67,669 | 67,669 |
| Payment of tax withholdings on settlement of rsus | 144,043 | 132,558 |
| Deferred offering costs paid | 28,769 | 27,763 |
| Common stock repurchased | 0 | - |
| Other financing activities | -64,946 | -44,086 |
| Net cash provided by financing activities | 5,779,106 | 4,083,046 |
| Net increase in cash, cash equivalents, and restricted cash | 932,858 | 17,750 |
| Cash and cash equivalents at beginning of period | 2,035,833 | - |
| Cash and cash equivalents at end of period | 2,968,691 | - |
CoreWeave, Inc. (CRWV)
CoreWeave, Inc. (CRWV)